Spots Global Cancer Trial Database for parathyroid hormone
Every month we try and update this database with for parathyroid hormone cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Observation of Histological Changes in Parathyroid Adenomas Following High Intensity Focused Ultrasound (HIFU) Treatment Procedure | NCT01060982 | Primary Parathy... | Ultrasonic abla... | 18 Years - | Theraclion | |
| Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization. | NCT00299780 | Lymphoma Multiple Myelom... Acute Myelogeno... | Stem cell mobil... | 18 Years - 75 Years | Massachusetts General Hospital | |
| Safety, Tolerability and Efficacy of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism | NCT01254565 | Secondary Hyper... | Etelcalcetide Placebo | 18 Years - | KAI Pharmaceuticals | |
| Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial Dose | NCT00891813 | Secondary Hyper... Renal Insuffici... Parathyroid Hor... Hemodialysis Hypercalcemia | Zemplar (parica... | 18 Years - | Abbott | |
| Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial Dose | NCT00891813 | Secondary Hyper... Renal Insuffici... Parathyroid Hor... Hemodialysis Hypercalcemia | Zemplar (parica... | 18 Years - | Abbott | |
| Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism | NCT01439867 | Chronic Kidney ... Hyperparathyroi... | Cinacalcet hydr... Standard of Car... | 28 Days - 2189 Days | Amgen | |
| Open-label Study to Assess the Long-term Safety and Efficacy of Etelcalcetide (Also Known as AMG 416 or KAI-4169) in Patients With Secondary Hyperparathyroidism | NCT01576146 | Secondary Hyper... | Etelcalcetide | 18 Years - | KAI Pharmaceuticals | |
| Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism | NCT01134562 | Hyperparathyroi... | Placebo Etelcalcetide | 18 Years - | KAI Pharmaceuticals | |
| Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism | NCT01439867 | Chronic Kidney ... Hyperparathyroi... | Cinacalcet hydr... Standard of Car... | 28 Days - 2189 Days | Amgen | |
| Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor | NCT00393380 | Leukemia, Myelo... Anemia, Aplasti... Myelofibrosis Lymphoma Hodgkin Disease Leukemia, Lymph... Leukemia, Myelo... Leukemia, Lymph... | Parathyroid Hor... | 18 Years - 45 Years | The Emmes Company, LLC | |
| Open-label Study to Assess the Long-term Safety and Efficacy of Etelcalcetide (Also Known as AMG 416 or KAI-4169) in Patients With Secondary Hyperparathyroidism | NCT01576146 | Secondary Hyper... | Etelcalcetide | 18 Years - | KAI Pharmaceuticals | |
| Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism | NCT01134562 | Hyperparathyroi... | Placebo Etelcalcetide | 18 Years - | KAI Pharmaceuticals | |
| Pediatric Chronic Kidney Disease Safety and Efficacy | NCT01277510 | Chronic Kidney ... Hyperparathyroi... Hyperparathyroi... Kidney Disease Secondary Hyper... | cinacalcet caps... placebo Standard of Car... | 6 Years - 17 Years | Amgen | |
| Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation. | NCT01939977 | Secondary Hyper... | Paricalcitol Calcifediol | 18 Years - | Fundación Senefro |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
